This paper is in the following e-collection/theme issue:

Proposals (non-eHealth) (41)

Published on in Vol 6, No 7 (2017): July

Natural Compounds for the Treatment of Psoriatic Arthritis: A Proposal Based on Multi-Targeted Osteoclastic Regulation and on a Preclinical Study

Natural Compounds for the Treatment of Psoriatic Arthritis: A Proposal Based on Multi-Targeted Osteoclastic Regulation and on a Preclinical Study

Natural Compounds for the Treatment of Psoriatic Arthritis: A Proposal Based on Multi-Targeted Osteoclastic Regulation and on a Preclinical Study

Authors of this article:

Shiqiang Deng1 Author Orcid Image ;   Jianwen Cheng1, 2, 3 Author Orcid Image ;   Jinmin Zhao1, 2, 3 Author Orcid Image ;   Felix Yao1 Author Orcid Image ;   Jiake Xu1, 2, 3 Author Orcid Image
Article Authors Cited by (9) Tweetations (2) Metrics

Journals

  1. Liu C, Cao Z, Zhang W, Tickner J, Qiu H, Wang C, Chen K, Wang Z, Tan R, Dong S, Xu J. Lumichrome inhibits osteoclastogenesis and bone resorption through suppressing RANKL‐induced NFAT activation and calcium signaling. Journal of Cellular Physiology 2018;233(11):8971 View
  2. Wang Q, Yao L, Xu K, Jin H, Chen K, Wang Z, Liu Q, Cao Z, kenny J, Liu Y, Tickner J, Xu H, Xu J. Madecassoside inhibits estrogen deficiency‐induced osteoporosis by suppressing RANKL‐induced osteoclastogenesis. Journal of Cellular and Molecular Medicine 2019;23(1):380 View
  3. Zhou L, Liu Q, Hong G, Song F, Zhao J, Yuan J, Xu J, Tan R, Tickner J, Gu Q, Xu J. Cumambrin A prevents OVX‐induced osteoporosis via the inhibition of osteoclastogenesis, bone resorption, and RANKL signaling pathways. The FASEB Journal 2019;33(6):6726 View
  4. Yang M, Xie J, Lei X, Song Z, Gong Y, Liu H, Zhou L. Tubeimoside I suppresses diabetes-induced bone loss in rats, osteoclast formation, and RANKL-induced nuclear factor-κB pathway. International Immunopharmacology 2020;80:106202 View
  5. Song D, Cao Z, Tickner J, Qiu H, Wang C, Chen K, Wang Z, Guo C, Dong S, Xu J. Poria cocos polysaccharide attenuates RANKL-induced osteoclastogenesis by suppressing NFATc1 activity and phosphorylation of ERK and STAT3. Archives of Biochemistry and Biophysics 2018;647:76 View
  6. Song D, Cao Z, Huang S, Tickner J, Li N, Qiu H, Chen X, Wang C, Chen K, Sun Y, Dong S, Xu J. Achyranthes bidentata polysaccharide suppresses osteoclastogenesis and bone resorption via inhibiting RANKL signaling. Journal of Cellular Biochemistry 2018;119(6):4826 View
  7. Nguyen U, Nguyen L, Kim B, Choi M, Yang I, Shin H, Da Silva Filho A. Natural Compound Mixture, Containing Emodin, Genipin, Chlorogenic Acid, Cimigenoside, and Ginsenoside Rb1, Ameliorates Psoriasis-Like Skin Lesions by Suppressing Inflammation and Proliferation in Keratinocytes. Evidence-Based Complementary and Alternative Medicine 2020;2020:1 View
  8. Lu Q, Jiang C, Hou J, Qian H, Chu F, Zhang W, Ye M, Chen Z, Liu J, Yao H, Zhang J, Xu J, Wang T, Fan S, Wang Q. Patchouli Alcohol Modulates the Pregnancy X Receptor/Toll-like Receptor 4/Nuclear Factor Kappa B Axis to Suppress Osteoclastogenesis. Frontiers in Pharmacology 2021;12 View
  9. Chen D, Chu F, Zhang G, Wang Q, Li Y, Zhang M, He Q, Yang J, Wang H, Sun P, Xu J, Chen P. 12-Deoxyphorbol 13-acetate inhibits RANKL-induced osteoclastogenesis via the attenuation of MAPK signaling and NFATc1 activation. International Immunopharmacology 2021;101:108177 View